Close Menu

Books in a Library


Recent Advances of Diagnosis and Treatment of Pulmonary Arterial Hypertension

The mechanisms of pulmonary arterial hypertension remain uncertain, and the diagnosis of pulmonary arterial hypertension is challenging. The major advances of the diagnostic modalities and management strategies include new uses of routine biomarkers including antinuclear antibody, B-type natriuretic peptide, circulating endothelial cells and microRNA in diagnosis; and microRNA, mesenchymal stem cells and remote postconditioning for pulmonary protection in treatment. Understanding the progress in terms of the mechanisms and concepts of pulmonary hypertension implicates significant improvement of the management protocols of this disorder. In this article, the advances of the diagnostic modalities and management strategies of PAH are discussed.


27 Sep, 2016
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 27 Oct, 2016


Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - microRNAs
Top of Page